Shots: Akili to receive $20M upfront, $105M as development & commercialization milestones, making the total the deal value $125M & royalties on sales of the products. Shionogi to get exclusive […]readmore
Shots: The companies entered into an agreement to assess insulin dose data from Novo Nordisk’ pre-filled insulin pen connected to the digital health tool marked with Abbott’s FreeStyle Libre system […]readmore
Shots: The BYOD project is initiated for All of Us Research Program, enrolling 1M participants to gather collective data for improving the ability of preventing and treating diseases based on […]readmore
Shots: The approval is based on clinical trials assessing Embrace in 141 patients including 80 pediatric with epilepsy aged 6 to 21 years (generalized tonic-clonic seizures) after winning clearance for […]readmore
Shots: The approval is based on trial results assessing reSET-O in 170 patients receiving either treatment-as-usual (TAU) + standard clinician interactions + buprenorphine or reSET-O + standard clinician interactions + […]readmore
Shots: The launch is in based on the results of study evaluating reSET vs outpatient therapy alone showing improved recovery & abstinence from patients’ substances of abuse with increased retention […]readmore
Shots: The SMART Suite will be developed on Philips HealthSuite digital platform, providing services and technical tools to facilitate secure, open data exchange between facilities, clinicians and patients SMART Suite […]readmore
Shots: The partnership will focus on exploring the usage of non-invasive wearable sweat sensor in measuring prognostic biomarkers in real time, monitoring patient’s response and in informing personalized treatment to […]readmore
Shots: Novo Nordisk launched Sophia Chatbot, available on Cornerstones4Care as “Ask Sophia “tab, directly answers questions and addresses concerns/forwards/ redirects when it doesn’t know the answer The launch is in […]readmore
Shots: Medtronic claims application of game design will help in motivating and encouraging diabetic people to achieve better health outcomes This PEP is initiated to promote MiniMed 670G system which […]readmore